Core Viewpoint - Ctrip Group-S (09961) maintains a "Buy" rating with Q3 2025 performance slightly exceeding expectations, net revenue increased by 16% year-on-year to 18.4 billion RMB, and operating profit margin stable at 30% [1] Financial Performance - Q3 revenue reached 18.4 billion RMB, a 16% year-on-year increase, slightly above the firm's and market expectations by 2% and 1% respectively [2] - Accommodation bookings grew by 14% year-on-year, while transportation ticketing revenue increased by 9%, accounting for 44% and 34% of total revenue, contributing 51% and 27% to revenue growth [2] - Gross profit rose by 15% year-on-year with a gross margin of 82%, remaining stable both year-on-year and quarter-on-quarter [2] - Operating profit was 5.6 billion RMB, an 11% year-on-year increase, exceeding the firm's and market expectations by 4% and 5% respectively, with an operating profit margin of 30% [2] - Adjusted net profit attributable to shareholders was 19.2 billion RMB, significantly above market expectations of 5.6 billion RMB, mainly reflecting gains from the disposal of overseas investment in MakeMyTrip [2] Operational Data - Domestic hotel ADR and ticket prices saw a slight decline in Q3, with domestic tourism revenue per capita increasing by 5% and total visits up by 13% year-on-year [3] - Outbound hotel and flight bookings increased by 20% year-on-year, and 40% compared to Q3 2019, indicating a faster recovery than the industry average [3] - International OTA hotel and flight bookings maintained over 60% year-on-year growth, with the Asia-Pacific market being the largest [3] - Inbound travel bookings more than doubled year-on-year [3] - TripGenie has expanded to over 200 countries, with user growth exceeding 200% year-on-year [3] Financial Forecast and Valuation - During the National Day holiday, outbound travel hotel and flight bookings increased by 30%, with notable growth in Europe and stable hotel ADR [4] - Q4 total revenue is expected to grow by 16% year-on-year, with accommodation and transportation bookings projected to increase by 15% and 12% respectively [4] - For 2026, total revenue is forecasted to grow by 14%, with adjusted net profit expected to reach 20.8 billion RMB and a profit margin of 29.6% [4] - The firm is optimistic about the company's long-term profit margin exceeding 30%, driven by supply advantages and improved profitability in overseas operations [4] - The valuation benchmark has been adjusted to 2026, with a target price raised to 693 HKD (9961.HK) / 89 USD (TCOM.US) based on a 20x 2026 P/E ratio [4] - The company continues to invest in AI and overseas markets while maintaining good ROI and financial discipline [4]

据去哪儿旅行数据，从当前到2025年年底，中国游客的错峰出境游需求依然旺盛。部分赴日游客转向其 他目的地，韩国目前已经取代日本，成为最受欢迎的出境游目的地。 （作者：罗晶晶,甘俊,实习生谢诗宇 编辑：章启良） 受近期日方涉台错误言论及当地治安恶化双重影响，外交部发布赴日旅行警示，国内各大航司已启动免 费退改机制。 记者实探多家旅社，虽未收到"停团"指令，但市场避险情绪升温。其中一家旅社销售表示，近期日本游 退单量激增，大量相关产品已做下架处理。 ...

Investment Rating - The report maintains a positive outlook on the overseas pharmaceutical sector, particularly focusing on innovative drugs and industry chain opportunities, with an investment rating of "Overweight" [1][6]. Core Insights - Multiple policies are supporting the development of the innovative drug industry, with domestic innovative drug transactions reaching historical highs in both value and quantity. The sector's valuation has rebounded from a low point, and leading companies are achieving profitability through increased commercial sales and licensing income [6][8]. - Companies like BeiGene are experiencing significant growth, with global sales exceeding $1 billion in Q3 2025, marking a 51% year-on-year increase. The company anticipates a positive GAAP operating profit for the full year 2025, raising its revenue guidance to $5.1-5.3 billion [1][6]. - Innovent Biologics is expanding its pipeline with a dual focus on oncology and non-oncology products, expecting to achieve positive non-IFRS net profit and EBITDA in 2024, with continued growth projected for 2025 [2][6]. - The report highlights the increasing R&D investments by leading pharmaceutical companies, which are enhancing their innovative pipelines and accelerating their transformation towards innovation [3][7]. Summary by Sections Section 1: Overseas Pharmaceuticals - The report emphasizes the focus on innovative drugs and the opportunities within the industry chain for 2026, noting the historical highs in transaction amounts and numbers for domestic innovative drugs going overseas [6][8]. - BeiGene's overseas sales are highlighted, with Q3 2025 global sales surpassing $1 billion and a significant year-on-year profit turnaround [1][6]. - Innovent Biologics is noted for its strategic partnerships and expected profitability in the coming years [2][6]. Section 2: Pharma Sector - Leading companies are rapidly increasing their R&D investments, which is expected to strengthen their innovative pipelines and global competitiveness [3][7]. - Companies like Hansoh Pharmaceutical and China Biologic Products are projected to see substantial growth in their innovative product revenues, with significant contributions expected in the coming years [3][7]. Section 3: CXO Sector - The report indicates a recovery in investment and financing for innovative drugs, which is likely to drive early-stage R&D investments and boost demand [8]. - Emerging fields such as peptides and ADCs are expected to open new growth opportunities, with a recommendation to focus on companies like WuXi AppTec and WuXi Biologics [8].

Core Insights - Ctrip Group reported strong financial performance for Q3 2025, with revenue reaching 18.3 billion yuan, a year-on-year increase of 16%, and a net profit of 19.9 billion yuan [1] - The company benefited from robust travel demand during the peak season, with both domestic and international markets showing healthy growth [1] Revenue Breakdown - Accommodation booking revenue was 8 billion yuan, up 18% year-on-year, driven by strong outbound travel and international hotel bookings [1] - Transportation ticketing revenue reached 6.3 billion yuan, a 12% increase year-on-year, supported by strong growth in international air bookings [1] - Vacation revenue was 1.6 billion yuan, growing 3% year-on-year, primarily due to the expansion of international product lines [1] - Business travel management revenue was 756 million yuan, up 15% year-on-year, as more companies adopted this service [1] International Business Performance - The international OTA platform saw total bookings increase by approximately 60%, with the Asia-Pacific region being the largest contributor [2] - Inbound travel bookings more than doubled year-on-year, with strong growth also observed in Europe and the U.S. [2] - Outbound hotel and flight bookings increased nearly 20% year-on-year, reaching 140% of the levels seen in the same period of 2019 [2] Demographic Trends - Demand from both senior and young travelers is strong, indicating a trend of intergenerational diversity [3] - The number of users in the "Old Friends Club" grew over 70%, with affluent senior travelers focusing on quality travel experiences [3] - Young travelers are increasingly driven by experiential tourism, with significant revenue growth in this segment due to events like concerts [3] Future Outlook - The company expects to achieve revenues of 61.56 billion yuan, 70.78 billion yuan, and 80.36 billion yuan for 2025-2027, with year-on-year growth rates of 15.5%, 15.0%, and 13.5% respectively [3] - Projected net profits for the same period are 31.92 billion yuan, 20.58 billion yuan, and 23.86 billion yuan, with growth rates of 87.0%, -35.5%, and 15.9% respectively [3] - Ctrip's domestic business advantages and potential growth in international markets suggest long-term investment value, with a target PE of 20.5X for 2026 [3]

Core Viewpoint - Ctrip Group reported strong financial performance in Q3 2025, with significant revenue growth driven by robust travel demand and successful international business expansion [1][2]. Financial Performance - The company achieved a revenue of 18.37 billion yuan in Q3 2025, representing a year-over-year increase of 15.5% [1]. - Gross margin stood at 81.7%, down 0.7 percentage points year-over-year [1]. - Operating profit reached 5.57 billion yuan, up 11.3% year-over-year [1]. - Net profit soared to 19.89 billion yuan, a remarkable year-over-year increase of 194.0%, primarily due to gains from the disposal of certain investments [1]. Revenue Breakdown - Accommodation booking revenue was 8.05 billion yuan, growing 18.3% year-over-year [1]. - Transportation ticketing revenue reached 6.31 billion yuan, up 11.6% year-over-year [1]. - Vacation business revenue was 1.61 billion yuan, increasing by 3.1% year-over-year [1]. - Business travel management revenue amounted to 0.76 billion yuan, up 15.2% year-over-year [1]. - Other business revenue was 1.65 billion yuan, showing a significant growth of 33.9% year-over-year [1]. International Business Growth - The international OTA platform saw total bookings increase by approximately 60% year-over-year in Q3 2025 [1]. - Inbound tourism bookings more than doubled, growing over 100% year-over-year [1]. - Outbound hotel and flight bookings reached 140% of the levels seen in the same period of 2019, with the Asia-Pacific region being a major contributor to this growth, exceeding 50% overall [1]. Cost Structure - Sales expense ratio was 22.8%, up 1.5 percentage points year-over-year, reflecting increased marketing investments in overseas markets [2]. - Management expense ratio was 6.2%, down 0.4 percentage points year-over-year [2]. - R&D expense ratio was 22.3%, down 0.7 percentage points year-over-year [2]. - Total expense ratio was 51.3%, an increase of 0.5 percentage points year-over-year [2]. Non-Recurring Gains - The sale of MakeMyTrip shares resulted in other income of 17.03 billion yuan in Q3 2025, a substantial increase from 1.78 billion yuan in the same period last year [2]. - This transaction led to a significant rise in corporate income tax expenses to 3.3 billion yuan, compared to 720 million yuan in the previous year [2]. Investment Outlook - The company is positioned as a leading domestic OTA, with steady growth in domestic operations and promising progress in international expansion [2]. - Revenue projections for 2025-2027 are estimated at 61.68 billion yuan, 70.16 billion yuan, and 79.54 billion yuan, with net profits of 31.65 billion yuan, 20.62 billion yuan, and 23.59 billion yuan respectively [2]. - The target market capitalization is set at 452.4 billion HKD, with a target price of 635 HKD per share, indicating a potential upside of 12.3% [2].

机构：中信建投证券 研究员：崔世峰/于伯韬 收入端略超预期。三季度携程实现营收183.67 亿（vsguidance181 亿），同比增长15.52%，其中交通票 务收入63.06 亿（vs guidance62 亿），同比增长11.61%，酒店收入80.47 亿（vsguidance79 亿），同比增 长18.30%，旅游度假收入16.06 亿（vsguidance17 亿），同比增长3.08%，商旅收入7.56 亿（vs guidance7.2亿）。三季度携程国内业务收入占比达65%左右，增速接近10%左右；出境业务收入占比接 近mid-teens，增速接近mid-teens；纯海外业务收入占比20%以上，增速在40%左右，其中Trip.com收入 占比13%左右，增速在60-65%左右。三季度国际业务保持强劲增长势头，国际OTA 平台总预订同比增 长超过60%，入境旅游预订同比增长超过100%，出境酒店和机票预订已全面超越2019 年疫情前同期的 140%水平。 受益于处置MMYT 部分股权影响，利润端大幅增长。携程三季度实现毛利润149.79 亿元，同比增长 14.58%，毛利率达到81.68%，同比 ...

记者丨高江虹 编辑丨高梦阳 11月18日，携程集团公布2025年第三季度财报，数据显示单季净利润达到199亿元，同比大幅增长 194%，创下净利润超过营业收入的罕见记录。 这一利润表现背后，是一项精明的跨境投资退出决策。携程通过出售所持印度在线旅游巨头 MakeMyTrip部分股权，一举获得约170亿元巨额收益。 "这主要得益于处置某些投资所得，"携程CFO王肖璠在业绩发布会上坦言。她所指的，正是携程对 MakeMyTrip这笔历时九年的投资。不过，剔除这笔投资收益，携程第三季度净利润并没有那么可观， 远低于去年同期的68亿元。 下一步，携程要如何向投资者描绘增长曲线？ | TCOM Financial Results Recap | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | RMB '00mn | 3Q23 | 4Q23 | 1Q24 | 2Q24 | 3Q24 | 4Q24 | 1Q25 | 2Q25 | 3025 | 3Q25E | var. | | ...

Core Viewpoint - Ctrip Group reported a significant increase in net profit for Q3 2025, reaching 19.9 billion RMB, a year-on-year growth of 194%, primarily driven by a strategic exit from its investment in MakeMyTrip, which generated approximately 17 billion RMB in revenue from the sale of shares [1][4]. Investment in MakeMyTrip - Ctrip's investment in MakeMyTrip began in January 2016 with a convertible bond of 180 million USD, marking its entry into the Indian market, which was seen as having high growth potential due to a rapidly rising middle class [4][5]. - The investment was strategically timed, as the IMF projected India's economic growth at 7.5% in 2016, with a significant increase in the middle-class population, providing a strong foundation for tourism consumption [4]. - Over nine years, Ctrip's stake in MakeMyTrip grew, with the book value of the investment reaching 6.2 billion RMB by the end of 2023 and 7.1 billion RMB by the end of 2024, indicating a stable appreciation [5][6]. - In June 2025, Ctrip sold part of its shares in MakeMyTrip for 2.5 to 3 billion USD, reducing its voting rights from 45.3% to 16.9%, transitioning from a strategic to a financial investor [5][6]. Growth Engines - Ctrip's management highlighted three main growth engines: AI technology, inbound tourism, and targeted market segmentation [8][9]. - AI is positioned as a core strategic pillar, with Ctrip's AI travel assistant, TripGenie, expanding its user base significantly, indicating a strong focus on enhancing customer experience through technology [8]. - The inbound tourism sector is identified as a rapidly growing area, with Ctrip noting that China's inbound tourism revenue as a percentage of GDP is significantly lower than that of developed countries, suggesting substantial growth potential [9]. - Ctrip is also focusing on the silver economy, targeting older consumers who have three times the spending power of younger demographics, and has seen significant growth in its "Old Friends Club" membership and transaction volume [9][10]. Market Challenges - Despite strong Q3 performance, the online travel industry faces renewed price competition, with major players like JD and Douyin entering the market [13]. - Ctrip's management emphasized the importance of quality service over price competition, as the market trends indicate a persistent decline in hotel and flight prices [13][14]. - The recovery of international business remains slow, with global airline capacity only at 88% of pre-pandemic levels, which could hinder faster growth for Ctrip's international operations [14]. - Ctrip is adopting a differentiated competitive strategy, including a global SOS service network for customer support and a refined marketing approach based on market maturity [14].

业内人士认为，这一政策落地，有望进一步便利中外人员的往来，不仅能为来华从事商务洽谈、投资考 察的外国人士提供流程简化服务，助力外资合作对接更高效推进，同时也能带动来华旅游、消费等相关 需求，间接为消费市场注入新活力。 入境流程更智能更省时 自2025年11月20日起，外国人来华前，可通过中国国家移民管理局政府网站、政务服务平台、"移民局 12367"APP和微信（支付宝）小程序、手机端扫描入境卡填报码等渠道，在网上填报入境相关信息。对 于不具备网上填报条件的外国人，可在抵达中国口岸出入境边防检查现场时，通过手机扫描二维码或使 用现场智能设备在网上填报入境信息，或者填写纸质外国人入境卡。7类符合条件的外国人还可免于填 报。 ● 本报记者 王舒嫄 11月20日，外国人入境卡网上填报政策落地实施，这一政策是国家移民管理局推出的支持扩大开放服务 高质量发展的创新举措之一。 这一举措使入境流程更智能更省时。今年以来，我国出入境政策不断优化调整，一系列便利化措施相继 出台，不仅为中外人员往来提供了更加便捷高效的服务，也彰显了我国坚持对外开放的坚定决心。 "中国游"持续升温 政策红利持续释放，今年以来我国入境游市场持续升温 ...

Core Insights - Ctrip Group reported a significant increase in net profit for Q3 2025, reaching 19.9 billion RMB, a year-on-year growth of 194%, marking a rare instance where net profit exceeded revenue [1] - The profit surge was primarily driven by a strategic exit from a cross-border investment, specifically the sale of part of its stake in Indian online travel giant MakeMyTrip, yielding approximately 17 billion RMB [1][5] - Excluding this investment gain, Ctrip's Q3 net profit was substantially lower than the previous year's 6.8 billion RMB [1] Investment in MakeMyTrip - Ctrip's investment in MakeMyTrip began in January 2016, with an initial investment of 180 million USD in convertible bonds, positioning Ctrip as a significant player in the Indian market [1][2] - The investment was based on the strong growth potential of the Indian economy and the rapid rise of its middle class, which was estimated to have reached 140 million people [2] - MakeMyTrip was already the largest OTA in India at the time of investment, holding a 15% market share in domestic flights and experiencing a 50% growth in hotel revenue [2] Strategic Developments - Ctrip's stake in MakeMyTrip was further solidified through a series of strategic equity operations, culminating in Ctrip holding approximately 49% of the voting rights by the end of 2024 [3] - The investment's value increased over the nine years, with Ctrip reporting a book value of 6.2 billion RMB and 7.1 billion RMB for its stake in MakeMyTrip by the end of 2023 and 2024, respectively [3] - In June 2025, Ctrip sold part of its Class B shares in MakeMyTrip for 2.5 to 3 billion USD, reducing its voting rights from 45.3% to 16.9%, transitioning from a strategic to a financial investor [3][4] Market Position and Future Growth - Despite relinquishing control over MakeMyTrip, Ctrip remains the largest minority shareholder, allowing it to benefit from the growth of the Indian online travel market, which has seen MakeMyTrip achieve over 50% market share in the OTA sector [4] - MakeMyTrip's total gross booking value (GBV) for FY2025 is projected to reach 9.8 billion USD, reflecting a year-on-year growth of 23.1% [4] Ctrip's Growth Engines - Ctrip's management highlighted three key growth engines: AI technology, inbound tourism, and targeted market segmentation [6][7] - The company is leveraging AI to enhance customer service and operational efficiency, with its AI travel assistant, TripGenie, experiencing over 200% user growth in the first half of 2025 [6] - Inbound tourism is identified as a rapidly growing segment, with significant potential for growth compared to developed countries, where inbound tourism revenue constitutes 1% to 5% of GDP [7] Market Challenges - Ctrip faces challenges from intensified price competition in the online travel industry, exacerbated by competitors like JD.com and Douyin [10] - Despite a strong Q3 performance, the overall market conditions remain challenging, with domestic hotel and flight prices showing only slight declines [10] - The recovery of international business is also constrained, with global airline capacity only reaching 88% of pre-pandemic levels, impacting Ctrip's growth potential [10] Competitive Strategy - In response to market challenges, Ctrip is adopting a differentiated competitive strategy, emphasizing high-quality service over price competition [11] - The company has announced a new 5 billion USD stock buyback plan, indicating a commitment to shareholder returns [11] - Ctrip's ongoing investment in technology and customer support services is crucial for maintaining its competitive edge in the evolving travel market [11]